Company: SUZ
Filing Date: 2025-09-02
Form Type: 424B2
Source: 0001104659-25-086037
Chunk: 8

Company: Suzano S.A.
Filing Date: 2025-09-02
Form: 424B2
Chunk 8
---
 with third parties in other locations that are outside the scope of the transaction.

The main assets included in
the transaction comprise 22 tissue manufacturing facilities located across 14 countries, with a total annual production capacity of approximately
1.0 million tons and commercial operations in more than 70 countries. As part of the transaction, the regional brands currently used by
K-C in the Included Regions will be transferred to the Joint Venture and certain global brands currently used by K-C will be licensed
to the Joint Venture for use in the Included Regions on a royalty-free, long-term basis. The transaction also includes a call option for
us to acquire K-C’s 49% interest in the Joint Venture, exercisable from and after the third anniversary of the closing date, subject
to the satisfaction of certain conditions. In certain circumstances, as an exception, we may exercise the call option earlier than the
third anniversary.

The purchase price of US$1.734
billion is expected to be paid in cash at the closing of the transaction and is subject to certain adjustments. We expect that the closing
of the transaction will occur in mid-2026, subject to the satisfaction of customary closing conditions, including regulatory approvals
and the completion of K-C’s reorganization of the business in the Included Regions. The transfer date of certain assets may vary
depending on specific requirements and conditions applicable to each jurisdiction.

As a result of the transaction,
upon the closing, the parties will enter into a Joint Venture agreement establishing certain rights and obligations related to the management,
control, operations, shareholding, and other matters concerning the Joint Venture. From an accounting perspective, we expect to consolidate
the Joint Venture as a subsidiary in our consolidated financial statements after closing of the transaction.

The transaction is aligned
with our long-term strategy of value-accretive growth with financial discipline, focusing on scalable businesses where we can leverage
our competitive strengths. The Joint Venture is expected to combine our industrial expertise and operational management capabilities with
K-C’s experience in brand management, marketing, and commercialization of regional and global brands, as well as its expertise in
managing operations across multiple regions worldwide.

<div align='center'>Suzano Netherlands B.V.</div>

Suzano Netherlands is a private
company with limited liability (besloten vennootschap met beperkte aansprakelijkheid) incorporated under the laws of the Netherlands,
with its corporate seat (statutaire zetel) in Amsterdam, the Netherlands, having its